Lean systems approaches to health technology assessment: a patient-focused alternative to cost-effectiveness analysis.

John F P Bridges

Research output: Contribution to journalArticle

Abstract

Many countries now use health technology assessment (HTA) to review new and emerging technologies, especially with regard to reimbursement, pricing and/or clinical guidelines. One of the common, but not universal, features of these systems is the use of economic evaluation, normally cost-effectiveness analysis (CEA), to confirm that new technologies offer value for money. Many have criticised these systems as primarily being concerned with cost containment, rather than advancing the interests of patients or innovators. This paper calls into question the underlying principles of CEA by arguing that value in the healthcare system may in fact be unconstrained. It is suggested that 'lean management principles' can be used not only to trim waste from the health system, but as a method of creating real incentives for innovation and value creation. Following the lean paradigm, this value must be defined purely from the patients' perspective, and the entire health system needs to work towards the creation of such value. This paper offers as a practical example a lean approach to HTA, arguing that such an approach would lead to better incentives for innovation in health, as well as more patient-friendly outcomes in the long run.

Original languageEnglish (US)
Pages (from-to)101-109
Number of pages9
JournalPharmacoEconomics
Volume24 Suppl 2
StatePublished - Dec 2006

Fingerprint

Biomedical Technology Assessment
Cost-Benefit Analysis
Motivation
Health
Technology
Cost Control
Guidelines
Delivery of Health Care
Costs and Cost Analysis

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Lean systems approaches to health technology assessment : a patient-focused alternative to cost-effectiveness analysis. / Bridges, John F P.

In: PharmacoEconomics, Vol. 24 Suppl 2, 12.2006, p. 101-109.

Research output: Contribution to journalArticle

@article{e66ceecee7fd444a80900163eb205990,
title = "Lean systems approaches to health technology assessment: a patient-focused alternative to cost-effectiveness analysis.",
abstract = "Many countries now use health technology assessment (HTA) to review new and emerging technologies, especially with regard to reimbursement, pricing and/or clinical guidelines. One of the common, but not universal, features of these systems is the use of economic evaluation, normally cost-effectiveness analysis (CEA), to confirm that new technologies offer value for money. Many have criticised these systems as primarily being concerned with cost containment, rather than advancing the interests of patients or innovators. This paper calls into question the underlying principles of CEA by arguing that value in the healthcare system may in fact be unconstrained. It is suggested that 'lean management principles' can be used not only to trim waste from the health system, but as a method of creating real incentives for innovation and value creation. Following the lean paradigm, this value must be defined purely from the patients' perspective, and the entire health system needs to work towards the creation of such value. This paper offers as a practical example a lean approach to HTA, arguing that such an approach would lead to better incentives for innovation in health, as well as more patient-friendly outcomes in the long run.",
author = "Bridges, {John F P}",
year = "2006",
month = "12",
language = "English (US)",
volume = "24 Suppl 2",
pages = "101--109",
journal = "PharmacoEconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",

}

TY - JOUR

T1 - Lean systems approaches to health technology assessment

T2 - a patient-focused alternative to cost-effectiveness analysis.

AU - Bridges, John F P

PY - 2006/12

Y1 - 2006/12

N2 - Many countries now use health technology assessment (HTA) to review new and emerging technologies, especially with regard to reimbursement, pricing and/or clinical guidelines. One of the common, but not universal, features of these systems is the use of economic evaluation, normally cost-effectiveness analysis (CEA), to confirm that new technologies offer value for money. Many have criticised these systems as primarily being concerned with cost containment, rather than advancing the interests of patients or innovators. This paper calls into question the underlying principles of CEA by arguing that value in the healthcare system may in fact be unconstrained. It is suggested that 'lean management principles' can be used not only to trim waste from the health system, but as a method of creating real incentives for innovation and value creation. Following the lean paradigm, this value must be defined purely from the patients' perspective, and the entire health system needs to work towards the creation of such value. This paper offers as a practical example a lean approach to HTA, arguing that such an approach would lead to better incentives for innovation in health, as well as more patient-friendly outcomes in the long run.

AB - Many countries now use health technology assessment (HTA) to review new and emerging technologies, especially with regard to reimbursement, pricing and/or clinical guidelines. One of the common, but not universal, features of these systems is the use of economic evaluation, normally cost-effectiveness analysis (CEA), to confirm that new technologies offer value for money. Many have criticised these systems as primarily being concerned with cost containment, rather than advancing the interests of patients or innovators. This paper calls into question the underlying principles of CEA by arguing that value in the healthcare system may in fact be unconstrained. It is suggested that 'lean management principles' can be used not only to trim waste from the health system, but as a method of creating real incentives for innovation and value creation. Following the lean paradigm, this value must be defined purely from the patients' perspective, and the entire health system needs to work towards the creation of such value. This paper offers as a practical example a lean approach to HTA, arguing that such an approach would lead to better incentives for innovation in health, as well as more patient-friendly outcomes in the long run.

UR - http://www.scopus.com/inward/record.url?scp=34247487979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247487979&partnerID=8YFLogxK

M3 - Article

C2 - 23389493

AN - SCOPUS:34247487979

VL - 24 Suppl 2

SP - 101

EP - 109

JO - PharmacoEconomics

JF - PharmacoEconomics

SN - 1170-7690

ER -